We assume that most who use GLP-1 agonists do not modify diet/lifestyle to create better behaviors, however, I wonder if those on GLP-1 agonists could be clinically at risk of, or are malnourished
Consequently, we may experience a loss of energy, a decrease in cognitive function, and the visible signs of aging
The key is maintaining your established levothyroxine schedule without interference from GLP-1 therapy initiation
Skin that feels warm to the touch
As clinical pharmacology data of oral semaglutide were characterised by high within-subject variability, potential changes to the disposition model obtained by including oral data were judged to be less credible, as the changes could be the result of changed estimation procedures and difficulties with the estimation
More severe GI side effects were seen in oral administration, and injections were associated with irritation at sites of administration [1]